glycine by spectral analyses, elucidation of hydrolysis products of the compound, and comparison of characteristics of the compound with those of a synthetic authentic compound.
We derived cephalosporin C (CPC) In the present paper, the isolation and the elucidation of the chemical structure of the compound C-2 are described.
Materials and Methods

Microorganism
The DCPC-producing mutant No. 40,1.2) which was derived from Cephalosporium acremonium No. 52-54, was used throughout this investigation.
Media and cultivation
The composition of the media and culture conditions were the same as reported elsewhere.') Determination of DCPC and compound C-2 An aliquot of a culture filtrate was subjected to electrophoresis (95 V/cm, 30 min) in 0.1 M formate buffer (pH 2.8)2), and DCPC or compound C-2 was eluted with a small volume of 0.01m potassium phosphate buffer (pH 7.0) from the corresponding zone. Deacetyl-CPC and compound C-2 were determined by measuring the absorbance of the eluates at 261 nm and 301 nm, respectively.
Thin-layer chromatography Thin-layer chromatography was performed at room temperature on thin-layer cellulose plates (E. Merck, layer thickness 0.1 mm, 20 x 20 cm). The following solvent systems were used: (A) n-butanol -acetic acid-water (3:1:1, v/v) ; (B) n-propanol -water (7:3. v/v) ; (C) acetonitrilewater (8:2, v/v) ; (D) isopropanol -water -pyridine (65:30:5. v/v) ; (E) methanol -n-propanol -water (6:2:1, v/v); (F) ethyl acetate-acetone-water (2:4:2, v/v).
Determination of amino acid component of compound C-2 After compound C-2 was hydrolyzed with 6 N HCI for 24 hours at 105°C in a sealed tube, a small portion of the hydrolyzate was subjected to the amino acid analyzer. Compound IV was synthesized according to the modified method of TERAO et ai.3) in the following manner. t-Butyl-benzoyl CPC (I) was used as a starting compound. Disodium salt of I (1.00 g) was dissolved in 20 ml of 0.01 M potassium phosphate buffer (pH 7.2), to which lipase Saiken 100 (1.60 g) was added. The mixture was stirred at 30°C for 16 hours, and then passed through a Millipore filter. The filtrate was applied on a column of Amberlite XAD-2 (3.5 55 cm). After the column was washed with distilled water, t-butyl-benzoyl DCPC (II) was eluted with 5 % aqueous ethanol (v/v). The fractions containing II were pooled and concentrated in iacuo. The concentrate was lyophilized to give 800 mg of powdery II. II (600 mg) was suspended in 10 ml of acetone and the resultant suspension was stirred at 5°C. Then, an aliquot (0.4 ml) of the solution (15 ml) containing 2.67 g of chromic anhydride and 4.52 ml of concentrated sulfuric acid was added dropwise over a period of 3 minutes, followed by stirring for a further 20 minutes at 5°C. After the reaction was completed, a major portion of the acetone was distilled off, followed by the addition of distilled water (10 ml). Extraction with ethylacetate (30 ml) was performed three times. The combined extracts were dried over anhydrous Na.SO" and the solvent was removed in vacuo to give 320 mg of 7B-[D-5-(t-butyl-benzoyl)amino-5-carboxyvaleramido]-9-oxo-11-hydroxy-11H-furano[4,3-c]-3-cephem (III). III (300 mg) was dissolved in a small volume of acetone, to which NaHCO3 (350 mg) was added. After stirring for 1 hour at room temperature, the solution was applied to a column of Amberlite XAD-2 (3.4 x 43 cm) and the column was washed with distilled water. Fractions containing 301 nm absorbing substance were collected and lyophilized to give 150 mg of
Synthesis of t-butyl-benzoyl compound C-2 Compound C-2 (220 mg) was dissolved in a small volume of distilled water, the pH of the solution was adjusted to 9.0 by the addition of 1 N NaOH, and acetone solution of p-(t-butyl)-benzoyl chloride (110 mg) added dropwise over a period of 1 hour. The mixture was stirred at room temperature for another 1 hour at pH 8.59.0.
Thereafter, the pH was brought to 7.5 by the addition of phosphoric acid and the major portion of the acetone was distilled off in i•acuo. The concentrate was applied on a column of Amberlite XAD-2 (3.5 x 43 cm) and the column was washed with distilled water. The fractions containing 301 nm absorbing substance were combined and lyophilized to give 120 mg of t-butyl-benzoyl compound C-2.
Analytical methods Amino acid analysis was performed by means of a Hitachi Model KLA-3B automatic amino acid analyzer. The UV spectrum was measured by a Hitachi Model 124 spectrophotometer. The IR spectrum was obtained with a Perkin-Elmer Model 21 infrared spectrometer. The NMR spectrum (100 MHz) was recorded on a Varian HA-100 spectrometer. Optical rotation measurement was made with a Perkin-Elmer Model 141 polarimeter. Materials Saiken 100 lipase was purchased from Osaka Saikin Kenkyusho. DEAE-Sephadex A-25 and Sephadex G-10 were obtained from Pharmacia Fine Chemicals. Amberlite XAD-2 was purchased from Rohm & Haas. After the column was washed with distilled water, the adsorbed substances were eluted with 7.5 liters of 60 % acetone containing 0.004 N NH4OH. The eluate was concentrated to 100 ml in vacuo below 40°C. The concentrate was applied on a DEAE-Sephadex A-25 column (3.5 x 23.5 cm) equilibrated with 0.1 M Tris-HCl buffer (pH 7.2). After the column was washed with 400 ml of the same buffer, compound C-2 was eluted with a continuous salt gradient method from zero to 1.0 M NaCl in the buffer (Fig. 3) . Frations containing compound C-2 (tube Nos. VOL. XXVIII NO. 5 THE JOURNAL OF ANTIBIOTICS 6070) were pooled, and then adsorbed on an activated carbon column (3.0 x 22.0 cm) after the pH of the fractions was adjusted to 5.5 with 1 N HCl. The column was washed well with distilled water, and then compound C-2 was eluted with 500 ml of 0.01 N NaOH containing 7 % n-butanol. The eluate was concentrated to 3 ml in vacuo. The concentrate was passed through a Sephadex G-10 column (3.0 x 137 cm) and compound C-2 was eluted with distilled water. Gel filtration was repeated with the same column. Compound C-2 fractions were combined and lyophilized to give 170 mg of a colorless powder.
Characterization and Identification of Compound C-2
The purified compound C-2 decomposed at above 162°C and was found to have the com The UV spectrum of compound C-2 in 0.01 M potassium phosphate buffer at pH 7.0 showed Amvx at 301 nm with E; _ 198 (Fig. 4) , and did not change by the addition of cephalosporinase2' from the mutant No. 3 of Aerobacter cloacae IFO 12937. Its IR spectrum also showed no bands corresponding to B-lactam bond at near 1750 cm-1 (Fig. 5) . Therefore, it seems that compound C-2 does not have a B-lactam ring.
As shown in Fig. 6 , the NMR spectrum of compound C-2 in D,O reveals the existence of a formyl group at 9.24 ppm (lH, s).
Signals at 1.72. 4 (4H, m) and 2.50 (2H, t, J=7Hz) are assigned to a-aminoadipic acid.
From the above data, compound C-2 was presumed to be the cephalosporoate of 7 -(5 -amino-5 -carboxypentamido) -3 -formyl-3-cephem-4-carboxylic acid. This chemical structure was finally proved by comparison of t-butylbenzoyl compound C-2 with IV synthesized from I (Fig. 7) . IV was essentially identical with t-butyl-benzoyl compound C-2 in UV, IR, and NMR spectra, and chromatographic behavior (Table 1) . Consequently, compound C-2 was concluded to be D-5-amino-5-carboxyvaleramido-(5-formyl-4-carboxy-2H, 3H, 6H-tetrahydro-1, 3-thiazinyl)glycine. 
Discussion
On the basis of the studies on the elucidation of the mechanism of the cleavage of the il-lactarn ring of cephalosporins by UVabsorption spectroscopy and the conventional chemical method, HAMILTON-MILLER et a1.5 stated that the above cleavage was accompanied by changes in the dihydrothiazine ring, and a tentative structure was proposed for the compound which had Ame .a 230 nm. They also reported that the cleavage pattern of cephalosporins in which C-3 side chain was a leaving group, such as acetoxy or pyridinium, was different from that of DCPC lactone. That is to say the opening of the (3-lactam of the lactone by mild hydrolysis appeared to occur without other changes in the structure and the resulting product, which showed Amax 265 nm, could be regarded as the corresponding cephalosporoate. Compound C-2 is a new cephalosporoate in which the (3-lactam of tentative 7-(5-amino-5-carboxypentamido)-3-formyl-3-cephem-4-carboxylic acid was probably opened due to its instability at near neutral pH. Compound C-2 was found to be accumulated only in the culture broths of mutants Nos. 20, 29, 36 and 40, which were defective in acetyl CoA:DCPC acetyltransferase and therefore could not accumulate CPC but could accumulate DCPC.1 Preliminary experiments indicated that a trace amount of compound C-2 was detected in the mycelia of all the above DCPC-producing mutants and the CPC-producing parent strain No. 52-54. It seems possible that DCPC was probably oxidized intracellularly to 7-(5-amino-5-carboxypentamido)-3-formyl-3-cephem-4-carboxylic acid, the P-lactam ring opened to form compound C-2, and then compound C-2 was excreted into the culture medium. The possibility was discounted that compound C-2 was derived from cephalosporoate of DCPC, because the opening of the (3-lactam ring of DCPC resulted in the formation of the compound with Amax 230 nm, which was subject to more extensive cleavage. 
